36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The inspection is now closed, and no regulatory action has been recommended
Subscribe To Our Newsletter & Stay Updated